C Larbouret
Overview
Explore the profile of C Larbouret including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marzi L, Combes E, Vie N, Ayrolles-Torro A, Tosi D, Desigaud D, et al.
Br J Cancer
. 2016 Sep;
115(10):1223-1233.
PMID: 27685445
Background: Cetuximab, a monoclonal antibody against EGFR used for the treatment of colorectal cancer (CRC), is ineffective in many patients. The aim of this study was to identify the signalling...
2.
Allal A, Ares C, Dulguerov P, Tschanz E, Verdan C, Mhawech P, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:89-108.
PMID: 27137923
No abstract available.
3.
Leconet W, Larbouret C, Chardes T, Thomas G, Neiveyans M, Busson M, et al.
Oncogene
. 2013 Nov;
33(47):5405-14.
PMID: 24240689
AXL receptor tyrosine kinase (RTK) is implicated in proliferation and invasion of many cancers, particularly in pancreatic ductal adenocarcinoma (PDAC), for which new therapeutic options are urgently required. We investigated...
4.
Larbouret C, Robert B, Bascoul-Mollevi C, Penault-Llorca F, Ho-Pun-Cheung A, Morisseau S, et al.
Ann Oncol
. 2009 Nov;
21(1):98-103.
PMID: 19889608
Background: Pancreatic carcinoma remains a treatment-refractory cancer with a poor prognosis. Here, we compared anti-epidermal growth factor receptor (EGFR) and anti-HER2 monoclonal antibodies (2mAbs) injections with standard gemcitabine treatment on...
5.
Azria D, Coelho M, Larbouret C, Lemanski C, Serre A, Ychou M, et al.
Cancer Radiother
. 2005 Feb;
8 Suppl 1:S106-13.
PMID: 15679255
Gemcitabine is pyrimidine analog which has demonstrated antitumoral activity in a variety of solid tumors. Laboratory studies demonstrating that gemcitabine is a potent radiosensitizer led to a variety of trials...
6.
Azria D, Larbouret C, Garambois V, Kramar A, Martineau P, Robert B, et al.
Br J Cancer
. 2003 Nov;
89(10):1987-94.
PMID: 14612914
The aim of this study was to treat carcinoembryonic antigen (CEA)-expressing pancreatic carcinoma cells with tumour necrosis factor alpha (TNFalpha) and simultaneous radiation therapy (RT), using a bispecific antibody (BAb)...